title: Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis.
authors.forename: Kristian
authors.initials: K
authors.lastname: Angeby
authors.forename: Christian G
authors.initials: CG
authors.lastname: Giske
authors.forename: Pontus
authors.initials: P
authors.lastname: Juréen
authors.forename: Thomas
authors.initials: T
authors.lastname: Schön
authors.forename: Jotam G
authors.initials: JG
authors.lastname: Pasipanodya
authors.forename: Tawando
authors.initials: T
authors.lastname: Gumbo
mesh_terms: D000995:Antitubercular Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000995:Antitubercular Agents